"The US Food and Drug Administration (FDA) has approved Andexxa (coagulation factor Xa [recombinant] inactivated-zhzo) to reverse the anticoagulation effects of factor Xa inhibitors when needed due to life-threatening or uncontrolled bleeding, Portola Pharmaceuticals has announced.
An estimated 4 million people are taking factor Xa inhibitors, such as rivaroxaban (Xarelto, Bayer/Janssen Pharmaceuticals) and apixaban (Eliquis, Bristol-Myers Squibb), but until now, there has been no approved reversal agent.
Last month, the FDA gave full approval to idarucizumab (Praxbind, Boehringer Ingelheim) to reverse the anticoagulant effect of dabigatran (Pradaxa, Boehringer Ingelheim), a direct thrombin inhibitor, in the event of urgent surgery or life-threatening or uncontrolled bleeding."
Full article here: medscape.com/viewarticle/89...
I think it's good news -but then again Andexxa will need to be approved in Europe before we can start using it over here...
Interesting News and Information
DVT and Rivaroxaban 
NICE recommends Rivaroxaban (Xarelto) for treatment of deep vein thrombosis and pulmonary embolism
